Arima Genomics announces a new study showing that the Aventa™ lymphoma test resolves diagnostic ambiguity and guides care in ...

Multiple myeloma (MM) treatment has changed tremendously, with significant improvement in patient out-comes. One group with a suboptimal benefit is patients with high-risk cytogenetics, as tested by ...

Javier Pinilla-Ibarz, MD, PhD: In terms of diagnosis and prognosis for chronic lymphocytic leukemia, we initially have to perform a technique called flow cytometry that will really indicate the ...